Senior Director
Pfizer
Dr. Ravi Shankar Singh, PhD, is currently a Director of Clinical Pharmacology at Pfizer. Currently, he leads development of various projects in inflammation and immunology and anti-infectives including oral protease inhibitor for COVID-19. Before joining Pfizer, he worked at Abbvie, University of Florida, Central Drug Research Institute (an Indian government research institute) and Dr. Reddy’s lab in India. His experience spans from discovery to late phase drug development across various organizations in various therapeutic areas including inflammation and immunology, anti-infectives, oncology and HCV.
Dr. Singh received his M. Pharm from BITS Pilani, India and PhD in pharmacokinetics at the University of Saskatchewan, Canada. He has more than 30 publications in peer reviewed journals and has authored four book chapters. He has presented his research work in several international conferences and his work has received several awards.
Disclosure information not submitted.
Friday, March 18, 2022
1:15 PM – 2:15 PM ET
.png)